Epsilon Healthcare Limited (ASX:EPN)

Market Cap	9.34M +29.5%
Revenue (ttm)	13.58M +121.4%
Net Income	64.39K
EPS	0.00
Shares Out	389.10M
PE Ratio	177.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,393
Open	0.0240
Previous Close	0.0230
Day's Range	0.0230 - 0.0240
52-Week Range	0.0190 - 0.0400
Beta	0.59
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Epsilon Healthcare

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPN

Financial Performance

In 2025, Epsilon Healthcare's revenue was 9.39 million, an increase of 67.74% compared to the previous year's 5.60 million. Losses were -1.28 million, -76.73% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error